Inici › Leucèmia limfoblàstica aguda › Carolina del Nord › Durham
Assaigs clínics de Leucèmia limfoblàstica aguda a Durham, NC
13 estudis de Leucèmia limfoblàstica aguda busquen participants en centres de Durham i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Durham VA Medical Center, Durham
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ReclutantFase 1/2
- Duke University Medical Center, Durham
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutantFase 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
ReclutantVoluntaris sans benvinguts
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
ReclutantFase 1/2
- Research Site, Durham
- Research Site, Chapel Hill · a 10 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutantEstudi observacional
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi
Registry of Older Patients With Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
A Study of Revumenib and Mezigdomide in People With Leukemia
ReclutantFase 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · a 10 mi
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutantFase 1
- University of North Carolina, Chapel Hill · a 10 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ReclutantFase 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · a 10 mi
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ReclutantFase 2
- University of North Carolina, Chapel Hill · a 10 mi
Pharmacokinetics of Drugs Administered to Children
ReclutantEstudi observacional
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
Assaigs de Leucèmia limfoblàstica aguda en altres ciutats
- Houston, TX28 estudis
- New York City, NY24 estudis
- Baldwin Park, CA21 estudis
- Seattle, WA21 estudis
- Chicago, IL19 estudis
- Atlanta, GA19 estudis
- Philadelphia, PA16 estudis
- Memphis, TN16 estudis
- Washington, DC16 estudis
- Boston, MA15 estudis
- Los Angeles, CA14 estudis
- Mountain View, CA13 estudis
Altres estudis a Durham
- Càncer de mama63 estudis
- Càncer (tots els tipus)58 estudis
- Càncer de pulmó de cèl·lules no petites39 estudis
- Mieloma múltiple37 estudis
- Càncer metastàtic33 estudis
- Leucèmia mieloide aguda33 estudis
- Càncer de pulmó32 estudis
- Càncer de pròstata32 estudis
- Càncer colorrectal28 estudis
- Leucèmia limfàtica crònica27 estudis
- Càncer d'ovari27 estudis
- Insuficiència cardíaca26 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.